The HFSA Virtual AHFTC Board Certification Review 2022 will be comprised of renowned heart failure experts presenting curriculum that has been tailored to the actual ABIM AHFTC examination blueprint. The educational content is rigorous, up-to-date, scientifically fair, and balanced, and meets the needs of heart failure providers who care for patients with heart failure. The live program took place August 12-14, 2022.
Content:
Day 1
Session 1 : Cardiac Transplantation
-Welcome and HFSA Introduction
Akshay Desai, MD, MPH, FHFSA
John Barnes, HFSA CEO
-Advanced Heart Failure: Defining the Phenotype and
Patient Selection for Advanced Therapies (with LIVE
Q&A)
Nancy Sweitzer, MD, PhD, FHFSA
-Immunology: The Basics, PRA, Sensitization,
Crossmatch( PDF)
Sean Pinney, MD
LIVE Q&A:
-Managing Immunosuppression and Drugs
-Heart Transplant, Clinical Outcomes and Complications
Michelle Kittleson, MD, PhD
-Heart Transplant, Clinical Outcomes and Complications
Michelle Kittleson, MD, PhD
Day 2
-Welcome and Introductions (LIVE)
Akshay Desai, MD, MPH, FHFSA
SESSION II: Key Issues in HF Management (Part I)
-Hemodynamics in HF II (with LIVE Q&A)
James C. Fang, MD, FHFSA
-Optimal Medical Therapy for HFrEF (1)
Mark Drazner, MD, MSc, FHFSA
-Optimal Medical Therapy for HFrEF (2)
Mark Drazner, MD, MSc, FHFSA
-LIVE Q&A:
-Optimal Medical Therapy for HFrEF
Mark Drazner, MD, MSc, FHFSA
-HFpEF: Epidemiology, Risk Factors, Diagnosis,
Management – for the boards (with LIVE Q&A)
Sanjiv Shah, MD
SESSION II: Key Issues in HF Management (Part II)
-Management of the Hospitalized HF Patient
Maria Rosa Costanzo, MD
-Pulmonary Hypertension – Therapy (with LIVE Q&A)
Jonathan Rich, MD, FHFSA
-Management of Common Arrhythmias – Atrial Fib and
Flutter
Roderick Tung, MD
-LIVE Q&A:
-Management of Common Arrhythmias I – Atrial Fib and
Flutter
-Management of Common Arrhythmias II
Roderick Tung, MD
-Device Therapy in Heart Failure I – Sudden Death
Prevention
Wendy Tzou, MD, FACC, FHRS
-Device Therapy in Heart Failure II – CRT
Wendy Tzou, MD, FACC, FHRS
-LIVE Q&A:
-Device Therapy in Heart Failure I – Sudden Death
Prevention
-Device Therapy in Heart Failure II – CRT
Wendy Tzou, MD, FACC, FHRS
SESSION II: Key Issues in HF Management (Part III)
-Management of Comorbidities in Heart Failure – Iron
Deficiencies/Anemia (with LIVE Q&A)
Maria Rosa Costanzo, MD
-Cardio Renal Failure Interactions in Heart Failure
(with LIVE Q&A)
Jeff Testani, MD, MTR
SESSION III: Specific Heart Failure Syndromes
-Specific Etiologies of HF I: Common Etiologies – CAD,
ETOH, Peripartum, Myocarditis (with LIVE Q&A)
Akshay Desai, MD, MPH, FHFSA
-Specific Etiologies of HF II: Inherited HF syndromes
including HCM, ARVC, and LVNC (with LIVE Q&A)
Jane Wilcox, MD, MSc, FHFSA
-Specific Etiologies of HF III: Infiltrative Disorders
and Restrictive Cardiomyopathy – Amyloidosis,
Sarcoidosis, Hemochromatosis, Fabry (with LIVE Q&A)
Sanjiv Shah, MD
-Q&A Faculty Panel – Day 2
Q&A Faculty Panel
Program Co-Chairs
Day 3
-Welcome and Introductions (LIVE)
Akshay Desai, MD, MPH, FHFSA
SESSION IV: Shock/MCS
-Cardiogenic Shock Management (with LIVE Q&A)
Nancy Sweitzer, MD, PhD, FHFSA
-MCS I: Durable MCS Devices and Outcomes (with LIVE
Q&A)
Joseph Rogers, MD
-MCS II: Temporary Support Devices and ECMO for the
Boards
Jennifer Cowger, MD, MS
-LIVE Q&A
MCS IV: Interactive Shock and Device Management (Note:
Live Session)
Daniel Burkhoff, MD, PhD
Jennifer Cowger, MD, MS
Joseph Rogers, MD
Nancy Sweitzer, MD, PhD, FHFSA
SESSION V: Special Topics in HF
-Assessment of Functional Capacity including
Cardiopulmonary Exercise Testing (with LIVE Q&A)
Gregory Lewis, MD
-Healthcare Disparities in HF (with LIVE Q&A)
Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA
-Issues in Chronic HF Disease Management – Biomarkers,
Remote Monitoring, Lifestyle Interventions (with LIVE
Q&A)
Akshay Desai, MD, MPH, FHFSA
-Management of Left Sided Valvular Heart Disease in
Heart Failure including Functional MR, Low Gradient AS
(with LIVE Q&A)
Jane Wilcox, MD, MSc, FHFSA
-Adult Congenital Heart Disease for the HF Specialist
(with LIVE Q&A)
Eric Krieger, MD
Q&A Faculty Panel – Day 3
-Q&A Faculty Panel
Program Co-Chairs
————-
Heart Failure Fundamentals
-Heart Failure Epidemiology and Risk Factors
-Pathophysiology I: Cellular and Energetic onsideration
-Pathophysiology II: Hemodynamic, Structural, and
Neurohormonal Considerations
-Diagnosis and Clinical Assessment
-Cardio-Oncology for the Heart Failure Boards
– Clinico-Pathologic Correlates in Heart Failure Images
for the Heart Failure Boards
-Statistics for the HF Board
-Hemodynamics in Heart Failure
-Pulmonary (arterial) hypertension:Classification and
Evaluation
-Comorbidities in Heart Failure: Focus on Diabetes and
COPD
-RV Failure and TR Management
-Management of Comorbidities in Heart Failure – Sleep
Disorder
